戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                                             As described previously for HDAC3, the neurotoxic effect of H
2                                                             As described previously in Brassica, the S haplotypes of A. l
3                                                             As described previously, a binding site for the integration h
4                                                             As described previously, approximately 50% of the animals dev
5                                                             As described previously, continuum models, such as the Smoluc
6                                                             As described previously, HIV transmission was associated with
7                                                             As described previously, in a degradation system utilizing ra
8                                                             As described previously, screening this library for sequences
9                                                             As described previously, the PDB2PQR web server addresses thi
10                                                             As described previously, this results, in part, from the incr
11                                                             As described previously, two distinct groups of sequences wer
12                                                             As described previously, ZO-1 also forms heterodimers with ZO
13 ltrasound was then confirmed in 121 of 124 patients (97.6%) as described previously.
14                                    Time control is achieved as described previously by compartmentalizing the reaction mi
15  knock-out female mice exhibited mild obesity and adiposity as described previously, as well as a significant delay in th
16 on-activated chloride currents in parotid acinar cells and, as described previously, displayed postnatal degeneration of
17 for mutations in SRSF2, U2AF1 (synonym U2AF35), ZRSR2, and, as described previously, SF3B1, in the context of other molec
18 factory neuroepithelium obtained from patients and cadavers as described previously.
19             We speculate that substrate-assisted catalysis, as described previously for certain RING-associated ubiquitin
20 ngly, the center of these MTOCs did not contain centrioles, as described previously for SAK/PLK4 overexpression [6].
21 translocation pathway through the VirB/D4 secretion channel as described previously for the T-DNA.
22 ice were enriched for membrane and other virion components, as described previously.
23 activity lie predominantly in one multi-neuronal dimension, as described previously.
24                      Two monkeys received a unilateral DRL, as described previously, which removed cutaneous and proprioc
25                               Reactive stroma was evaluated as described previously, and areas of RSG 3 in the entire tum
26 r-alpha messenger RNA and pulmonary fibrosis were evaluated as described previously.
27 port complex Mex67-Mtr2, for a role in tRNA nuclear export, as described previously in yeast.
28 bsequent stages of mass spectrometry in a parallel fashion, as described previously.
29 ger and older subpopulations differing in clinical features as described previously among patients identified under the V
30 ], [Formula: see text]), were also substantially heritable, as described previously.
31 t pathway produces dual incisions 5' to the site of the ICL as described previously but does not release the cross-link.
32 nt mutations eliminated the apparent inactivation of KCNQ1, as described previously.
33 ded odor and pattern separation for the discriminated odors as described previously.
34                  In group 8, rats were pretreated with ODQ (as described previously) before lipopolysaccharide (n = 8).
35                  In group 5, rats were pretreated with ODQ (as described previously) before lipoteichoic acid/peptidoglyc
36 s), their temperature dependence, and activation parameters as described previously for wild type ecDHFR.
37 s a function of bilayer thickness followed the same pattern as described previously.
38                           Evaluation of sTILs was performed as described previously.
39 ted corresponding antigens in sieve elements of the phloem, as described previously for all upstream enzymes transforming
40 orresponding to the end of phase 1 of the action potential, as described previously in the Brugada syndrome.
41  endoIII/Nth might not be a simple beta-elimination product as described previously.
42                             In addition to binding GTP-Rac1 as described previously, we find that POSH binds MLKs both in
43  and redesigned serotype-specific TS1 (rTS1) and TS4 (rTS4) as described previously in the conventional capsid and premem
44 e generated and their figures of merit are compared to sets as described previously in the literature (e.g. 4, 8, 12, 15
45 31)P magnetization transfer magnetic resonance spectroscopy as described previously.
46 ed by counting discrete foci of CD34 labeling in hot spots, as described previously.
47 mes found with accelerated growth rather than short stature as described previously.
48   In group 6, rats were pretreated with dimethyl sulfoxide (as described previously) before lipoteichoic acid/peptidoglyc
49                          Methods: (18)F-FAC was synthesized as described previously.
50  cells were identified by staining with HLA tetramers (tet) as described previously and the distribution of CD27 and CD38